Description
Recombinant Human INSL4 Protein (His Tag) | PKSH032370 | Gentaur US, UK & Europe Disrtribition
Synonyms: Early Placenta Insulin-Like Peptide; EPIL; Insulin-Like Peptide 4; Placentin; INSL4
Active Protein: N/A
Activity: Recombinant Human Early Placenta Insulin-Like Peptide is produced by our Mammalian expression system and the target gene encoding Ala26-Thr139 is expressed with a 6His tag at the C-terminus.
Protein Construction: Recombinant Human Early Placenta Insulin-Like Peptide is produced by our Mammalian expression system and the target gene encoding Ala26-Thr139 is expressed with a 6His tag at the C-terminus.
Fusion Tag: C-6His
Species: Human
Expressed Host: Human Cells
Shipping: This product is provided as lyophilized powder which is shipped with ice packs.
Purity: > 95 % as determined by reducing SDS-PAGE.
Endotoxin: < 1.0 EU per µg as determined by the LAL method.
Stability and Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Molecular Mass: 13.6 kDa
Formulation: Lyophilized from a 0.2 μm filtered solution of 20mM Tris, 150mM NACl, pH 8.0.
Reconstitution: Please refer to the printed manual for detailed information.
Background: Early Placenta Insulin-Like Peptide (INSL4) belongs to the insulin family. INSL4 is expressed in the early placental cytotrophoblast and syncytiotrophoblast INSL4 is a secreted protein and a precursor that undergoes post-translational cleavage to produce 3 polypeptide chains, A-C, that form tertiary structures composed of either all three chains, or just the A and B chains. INSL4 plays an important role in the development of trophoblast and in the regulation of bone formation.
Research Area: Signal Transduction, Developmental Biology,
